King's College London, Strand, London, United Kingdom.
Ann Surg. 2012 Mar;255(3):427-32. doi: 10.1097/SLA.0b013e318246591f.
The objective of this study was to perform an analysis of global cancer surgery research and development trends over the last 10 years across 21 countries.
Surgery is the main modality for cancer cure and control globally. Yet, in comparison to other areas such as cancer drugs, we know little about ongoing research activities to inform policymakers.
Two subfield filters, surgery research and oncology, were developed and applied to Web of Science. The intersection of these 2 filters identified papers in surgical oncology, and their bibliographic details were downloaded for analysis. This included matching of 5-year citation counts to the papers, impact factor, geographical analysis by country, translational collaboration, involvement in clinical trials, citation on clinical guidelines, and percentage of reviews.
Surgical oncology represents about 9% of all cancer research-low in comparison with surgery's contribution to cancer treatment. The US published the most, followed by Japan which had a high relative commitment to surgery within cancer research, followed by the large West European countries. Although Sweden's papers were relatively basic, it participated the most in clinical trials. Its papers were also the most cited on clinical guidelines, but contained relatively few reviews, where the UK, Greece, and Belgium scored best. Surgical oncology papers are generally not well cited compared with cancer research overall, but on this measure the Netherlands, the US, and Sweden scored best. International collaboration was measured relative to what might have been expected, on this indicator Canada, Switzerland, and the US were the best performers.
Globally, low activity-low funding cycle needs to be addressed by new national and supranational policies to support surgical oncology research.
本研究旨在分析过去 10 年全球 21 个国家的癌症手术研究与发展趋势。
手术是全球癌症治疗和控制的主要手段。然而，与癌症药物等其他领域相比，我们对正在进行的研究活动以告知政策制定者知之甚少。
开发并应用了两个子领域过滤器（手术研究和肿瘤学）到 Web of Science。这两个过滤器的交集确定了外科肿瘤学论文，并下载其书目详细信息进行分析。这包括将 5 年引用计数与论文匹配、影响因子、按国家进行地理分析、转化合作、参与临床试验、引用临床指南以及评论的百分比。
外科肿瘤学约占所有癌症研究的 9%-与手术在癌症治疗中的贡献相比，这一比例较低。美国发表的论文最多，其次是日本，其在癌症研究中对手术的相对承诺较高，其次是大的西欧国家。尽管瑞典的论文相对基础，但它参与临床试验最多。其论文在临床指南上的引用也最多，但评论相对较少，英国、希腊和比利时得分最高。与癌症研究整体相比，外科肿瘤学论文的引用通常较低，但在这一指标上，荷兰、美国和瑞典的得分最高。国际合作是根据预期进行衡量的，在这一指标上，加拿大、瑞士和美国表现最好。
在全球范围内，需要通过新的国家和超国家政策来解决低活动-低资金周期的问题，以支持外科肿瘤学研究。
